Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -3.23% | -40.00% | -95.72% |
May. 08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Financials (USD)
Sales 2021 | 2.21M | Sales 2022 | 4.76M | Capitalization | 25.39M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -26M | EV / Sales 2021 | 31.5 x |
Net cash position 2021 | 20.53M | Net cash position 2022 | 433K | EV / Sales 2022 | 5.25 x |
P/E ratio 2021 |
-1.9
x | P/E ratio 2022 |
-0.96
x | Employees | 12 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.68% |
Latest transcript on DMK Pharmaceuticals Corporation
1 day | -3.23% | ||
1 week | -40.00% | ||
Current month | -16.67% | ||
1 month | -49.83% | ||
3 months | -34.92% | ||
6 months | -93.89% | ||
Current year | -95.72% |
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 23-10-15 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 19-08-25 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Vickie Reed
BRD | Director/Board Member | 62 | 22-05-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.03 | -3.23% | 24,142 |
24-05-09 | 0.031 | +3.33% | 45,258 |
24-05-08 | 0.03 | -10.98% | 83,135 |
24-05-07 | 0.0337 | +1.20% | 24,125 |
24-05-06 | 0.0333 | -33.40% | 41,581 |
Delayed Quote OTC Markets, May 10, 2024 at 03:52 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-95.72% | 303K | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- DMKPQ Stock